HealthEquity Statistics
Total Valuation
HealthEquity has a market cap or net worth of $8.07 billion. The enterprise value is $8.79 billion.
| Market Cap | 8.07B |
| Enterprise Value | 8.79B |
Important Dates
The last earnings date was Thursday, May 28, 2026, after market close.
| Earnings Date | May 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HealthEquity has 83.60 million shares outstanding. The number of shares has decreased by -2.51% in one year.
| Current Share Class | 83.60M |
| Shares Outstanding | 83.60M |
| Shares Change (YoY) | -2.51% |
| Shares Change (QoQ) | -1.49% |
| Owned by Insiders (%) | 1.97% |
| Owned by Institutions (%) | 105.71% |
| Float | 81.93M |
Valuation Ratios
The trailing PE ratio is 36.22 and the forward PE ratio is 19.77. HealthEquity's PEG ratio is 1.30.
| PE Ratio | 36.22 |
| Forward PE | 19.77 |
| PS Ratio | 6.04 |
| Forward PS | 5.59 |
| PB Ratio | 3.96 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 16.56 |
| P/OCF Ratio | 16.48 |
| PEG Ratio | 1.30 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.54, with an EV/FCF ratio of 18.03.
| EV / Earnings | 38.11 |
| EV / Sales | 6.58 |
| EV / EBITDA | 17.54 |
| EV / EBIT | 25.33 |
| EV / FCF | 18.03 |
Financial Position
The company has a current ratio of 3.44, with a Debt / Equity ratio of 0.48.
| Current Ratio | 3.44 |
| Quick Ratio | 2.85 |
| Debt / Equity | 0.48 |
| Debt / EBITDA | 1.95 |
| Debt / FCF | 2.02 |
| Interest Coverage | 6.33 |
Financial Efficiency
Return on equity (ROE) is 11.06% and return on invested capital (ROIC) is 9.65%.
| Return on Equity (ROE) | 11.06% |
| Return on Assets (ROA) | 6.46% |
| Return on Invested Capital (ROIC) | 9.65% |
| Return on Capital Employed (ROCE) | 10.95% |
| Weighted Average Cost of Capital (WACC) | 5.29% |
| Revenue Per Employee | $475,205 |
| Profits Per Employee | $81,984 |
| Employee Count | 2,814 |
| Asset Turnover | 0.40 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HealthEquity has paid $68.19 million in taxes.
| Income Tax | 68.19M |
| Effective Tax Rate | 22.81% |
Stock Price Statistics
The stock price has decreased by -5.47% in the last 52 weeks. The beta is 0.21, so HealthEquity's price volatility has been lower than the market average.
| Beta (5Y) | 0.21 |
| 52-Week Price Change | -5.47% |
| 50-Day Moving Average | 85.89 |
| 200-Day Moving Average | 88.10 |
| Relative Strength Index (RSI) | 70.04 |
| Average Volume (20 Days) | 1,025,363 |
Short Selling Information
The latest short interest is 4.61 million, so 5.51% of the outstanding shares have been sold short.
| Short Interest | 4.61M |
| Short Previous Month | 4.13M |
| Short % of Shares Out | 5.51% |
| Short % of Float | 5.62% |
| Short Ratio (days to cover) | 4.48 |
Income Statement
In the last 12 months, HealthEquity had revenue of $1.34 billion and earned $230.70 million in profits. Earnings per share was $2.67.
| Revenue | 1.34B |
| Gross Profit | 945.12M |
| Operating Income | 347.19M |
| Pretax Income | 298.89M |
| Net Income | 230.70M |
| EBITDA | 501.32M |
| EBIT | 347.19M |
| Earnings Per Share (EPS) | $2.67 |
Balance Sheet
The company has $265.37 million in cash and $984.68 million in debt, with a net cash position of -$719.31 million or -$8.60 per share.
| Cash & Cash Equivalents | 265.37M |
| Total Debt | 984.68M |
| Net Cash | -719.31M |
| Net Cash Per Share | -$8.60 |
| Equity (Book Value) | 2.05B |
| Book Value Per Share | 24.39 |
| Working Capital | 330.79M |
Cash Flow
In the last 12 months, operating cash flow was $489.88 million and capital expenditures -$2.25 million, giving a free cash flow of $487.64 million.
| Operating Cash Flow | 489.88M |
| Capital Expenditures | -2.25M |
| Depreciation & Amortization | 154.13M |
| Net Borrowing | -115.00M |
| Free Cash Flow | 487.64M |
| FCF Per Share | $5.83 |
Margins
Gross margin is 70.68%, with operating and profit margins of 25.96% and 17.25%.
| Gross Margin | 70.68% |
| Operating Margin | 25.96% |
| Pretax Margin | 22.35% |
| Profit Margin | 17.25% |
| EBITDA Margin | 37.49% |
| EBIT Margin | 25.96% |
| FCF Margin | 36.47% |
Dividends & Yields
HealthEquity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.51% |
| Shareholder Yield | 2.51% |
| Earnings Yield | 2.86% |
| FCF Yield | 6.04% |
Analyst Forecast
The average price target for HealthEquity is $115.56, which is 19.66% higher than the current price. The consensus rating is "Buy".
| Price Target | $115.56 |
| Price Target Difference | 19.66% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 7.21% |
| EPS Growth Forecast (3Y) | 13.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HealthEquity has an Altman Z-Score of 4.7 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.7 |
| Piotroski F-Score | 7 |